Skip to main content

MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals board to consider un-audited financial results

01 Jul 2016 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on July 28, 2016, to consider and approve Un-Audited Financial Results for the first quarter ended June 30, 2016 (Q1).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..